StockData
Vyome Holdings, Inc logo

Vyome Holdings, Inc (HIND) stock

HINDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$1.51−0.03 (-2.27%)

Close on Nov 18, 2026Market cap $10.60MP/E –Yield –

Vyome operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Vyome's operating income for the twelve months ending Jun 30, 2026 was -$11.92M. For fiscal 2025 it was -$10.45M. The highest annual figure on record is -$1.01M in fiscal 2024.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$10.45M–
FY2024Dec 31, 2024-$1.01M–
FY2023Dec 31, 2023-$15.38M–
FY2022Dec 31, 2022-$46.35M–
FY2021Dec 31, 2021-$57.88M–
FY2020Dec 31, 2020-$12.46M–
FY2019Dec 31, 2019-$23.23M–
FY2018Dec 31, 2018-$36.97M–
FY2017Dec 31, 2017-$34.39M–
FY2016Dec 31, 2016-$19.51M–
FY2015Dec 31, 2015-$14.93M–
FY2014Dec 31, 2014-$9.84M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$862.57K–
Q1 FY2026Mar 31, 2026-$1.13M–
Q4 FY2025Dec 31, 2025-$1.36M–
Q3 FY2025Sep 30, 2025-$8.57M–
Q2 FY2025Jun 30, 2025-$324.19K–
Q1 FY2025Mar 31, 2025-$199.00K–
Q4 FY2024Dec 31, 2024-$256.01K–
Q3 FY2024Sep 30, 2024-$280.98K–
Q2 FY2024Jun 30, 2024-$2.05M–
Q1 FY2024Mar 31, 2024-$2.21M–
Q4 FY2023Dec 31, 2023-$1.90M–
Q3 FY2023Sep 30, 2023-$3.88M–
Q2 FY2023Jun 30, 2023-$3.98M–
Q1 FY2023Mar 31, 2023-$5.63M–
Q4 FY2022Dec 31, 2022-$16.69M–
Q3 FY2022Sep 30, 2022-$12.30M–
Q2 FY2022Jun 30, 2022-$9.24M–
Q1 FY2022Mar 31, 2022-$8.11M–
Q4 FY2021Dec 31, 2021-$37.52M–
Q3 FY2021Sep 30, 2021-$14.42M–
Q2 FY2021Jun 30, 2021-$3.69M–
Q1 FY2021Mar 31, 2021-$2.26M–
Q4 FY2020Dec 31, 2020-$3.20M–
Q3 FY2020Sep 30, 2020-$2.17M–
Q2 FY2020Jun 30, 2020-$3.00M–
Q1 FY2020Mar 31, 2020-$4.91M–
Q4 FY2019Dec 31, 2019-$4.98M–
Q3 FY2019Sep 30, 2019-$3.74M–
Q2 FY2019Jun 30, 2019-$6.41M–
Q1 FY2019Mar 31, 2019-$8.10M–
Q4 FY2018Dec 31, 2018-$8.66M–
Q3 FY2018Sep 30, 2018-$6.64M–
Q2 FY2018Jun 30, 2018-$9.60M–
Q1 FY2018Mar 31, 2018-$12.07M–
Q4 FY2017Dec 31, 2017-$9.92M–
Q3 FY2017Sep 30, 2017-$9.14M–
Q2 FY2017Jun 30, 2017-$7.64M–
Q1 FY2017Mar 31, 2017-$7.69M–
Q4 FY2016Dec 31, 2016-$7.53M–
Q3 FY2016Sep 30, 2016-$4.45M–

More Vyome figures

See a number that looks wrong?